Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia

Background: Omalizumab efficacy and safety in children older than 6 years has been clearly demonstrated in controlled clinical trials, but only in few real-life studies. Objective: To assess the response with omalizumab addition in children with moderate to severe persistent asthma in real-life con...

Full description

Bibliographic Details
Main Authors: Olga Morales-Múnera, Ángela Pedraza, Laura Niño-Serna
Format: Article
Language:English
Published: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2018-07-01
Series:Revista Alergia México
Subjects:
Online Access:http://revistaalergia.mx/ojs/index.php/ram/article/view/510